Zobrazeno 1 - 10
of 680
pro vyhledávání: '"Ocriplasmin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Miguel A. Quiroz-Reyes, Erick A. Quiroz-Gonzalez, Miguel A. Quiroz-Gonzalez, Virgilio Lima-Gomez
Publikováno v:
International Journal of Retina and Vitreous, Vol 9, Iss 1, Pp 1-16 (2023)
Abstract Background We conducted a systematic review to compare the effects of pneumatic vitreolysis (PV), enzymatic vitreolysis (EVL) with ocriplasmin, and pars plana vitrectomy (PPV) on vitreomacular traction (VMT) syndrome and macular holes (MHs)
Externí odkaz:
https://doaj.org/article/eda24624d67e4414a4c76feb9f478edf
Autor:
Roghayyeh Baghban, Safar Farajnia, Younes Ghasemi, Mojtaba Mortazavi, Naser Samadi, Nosratollah Zarghami
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 3, Pp 564-569 (2021)
Purpose: Ocriplasmin (Jetrea TM) is a FDA approved recombinant enzyme utilized in the treatment of vitreomacular adhesion (VMA). This is a recombinant C-terminal fragment of human plasmin produced using yeast Pichia pastoris. Since ocriplasmin does n
Externí odkaz:
https://doaj.org/article/cc8f0425eaac4dbeb7a40c1067f1cf19
Autor:
Pradhan, Deepti, Agarwal, Lalit, Joshi, Ichhya, Kushwaha, Anamika, Aditya, Kshitij, Kumari, Archana
Publikováno v:
GMS German Medical Science, Vol 20, p Doc07 (2022)
Since the era when macular hole was considered untreatable, macular hole surgery has come a long way to being one of the most successful surgeries. Internal limiting membrane (ILM) peeling has been an essential step of macular hole surgery since the
Externí odkaz:
https://doaj.org/article/2337af6c5e5c48c0971973dd68a2e577
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 16, Pp 42-55 (2021)
Purpose: To assess the effect of patient baseline characteristics on the efficacy of ocriplasmin treatment for symptomatic vitreomacular adhesion (VMA) with full-thickness macular hole (FTMH) from phase 3/4 studies. Methods: Patients with sympto
Externí odkaz:
https://doaj.org/article/419e24ce70aa40b79e7bc5ec8bebb317
Autor:
Claudio Furino, Alfredo Niro, Luigi Sborgia, Michele Reibaldi, Francesco Boscia, Giovanni Alessio
Publikováno v:
Taiwan Journal of Ophthalmology, Vol 11, Iss 3, Pp 259-265 (2021)
PURPOSE: The purpose is to evaluate functional changes after ocriplasmin injection to treat vitreomacular traction (VMT) by microperimetry. MATERIALS AND METHODS: Prospective interventional study on patients underwent an intravitreal ocriplasmin inje
Externí odkaz:
https://doaj.org/article/5a071b368633491f8b41aa0ebd0fe854
Autor:
Roghayyeh Baghban, Safar Farajnia, Younes Ghasemi, Reyhaneh Hoseinpoor, Azam Safary, Mojtaba Mortazavi, Nosratollah Zarghami
Publikováno v:
Biological Procedures Online, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background Ocriplasmin (Jetrea) is using for the treatment of symptomatic vitreomacular adhesion. This enzyme undergoes rapid inactivation and limited activity duration as a result of its autolytic nature after injection within the eye. More
Externí odkaz:
https://doaj.org/article/383688f8051b48f3b6b5790dcd4b67fc
Publikováno v:
Guoji Yanke Zazhi, Vol 20, Iss 11, Pp 1907-1912 (2020)
Idiopathic macular hole(IMH)refers to a full-thickness tissue defect of the retinal neuroepithelial layer in the macular region without obvious etiology. At present, with the gradual deepening of the understanding of IMH and the continuous innovation
Externí odkaz:
https://doaj.org/article/a307d23e233e4e15a854f14ef703acc7
Publikováno v:
Clinical Ophthalmology, Vol Volume 14, Pp 81-88 (2020)
Sasha Hubschman, 1 Michael J Venincasa, 1 Ajay E Kuriyan, 2 Jayanth Sridhar 1 1Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USA; 2Department of Ophthalmology, Flaum Eye Institute
Externí odkaz:
https://doaj.org/article/c588af2ed6e44b10b08a9c7c7de94ede
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Symptomatic vitreomacular adhesion (sVMA) impedes visual acuity and quality. Ocriplasmin is a recombinant protease, which may be injected into the vitreous cavity to treat this condition, yet controversy remains with respect to its effectiveness and
Externí odkaz:
https://doaj.org/article/30b7136926d04591bb1096c126daa553